155 related articles for article (PubMed ID: 37465951)
1. Efficacy and safety of offline extracorporeal photopheresis in cutaneous T-cell lymphomas: A retrospective study.
Moreno-Vílchez C; Muniesa C; González-Barca E; García-Muñoz N; Ortega-Sánchez S; Servitje O
Photodermatol Photoimmunol Photomed; 2023 Nov; 39(6):667-669. PubMed ID: 37465951
[No Abstract] [Full Text] [Related]
2. [Photopheresis for cutaneous T-cell lymphomas].
Laroche L
Ann Dermatol Venereol; 2005 Sep; 132 Spec No 2():5S37-8. PubMed ID: 16385898
[No Abstract] [Full Text] [Related]
3. A case of poikiloderma vasculare atrophicans, a rare variant of cutaneous T-cell lymphoma, responding to extracorporeal photopheresis.
Kreuter A; Hoffmamm K; Altmeyer P
J Am Acad Dermatol; 2005 Apr; 52(4):706-8. PubMed ID: 15793532
[No Abstract] [Full Text] [Related]
4. Extracorporeal photopheresis and interferon-alpha in advanced cutaneous T-cell lymphoma.
Dippel E; Schrag H; Goerdt S; Orfanos CE
Lancet; 1997 Jul; 350(9070):32-3. PubMed ID: 9217723
[No Abstract] [Full Text] [Related]
5. Cutaneous T-cell lymphoma and cutaneous graft-versus-host disease. Two indications for photopheresis in dermatology.
Girardi M; Heald PW
Dermatol Clin; 2000 Jul; 18(3):417-23, viii. PubMed ID: 10943537
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of extracorporeal photopheresis in a diverse cohort of patients with cutaneous T-cell lymphoma: a retrospective study at a tertiary care hospital.
Weiner DM; Kumar P; Varadhan R; Sweren R; Kim N; Rozati S
J Dermatolog Treat; 2024 Dec; 35(1):2312250. PubMed ID: 38331434
[No Abstract] [Full Text] [Related]
7. Anaphylaxis following administration of extracorporeal photopheresis for cutaneous T cell lymphoma.
Tran J; Morris L; Vu A; Reddy S; Duvic M
Dermatol Online J; 2020 Sep; 26(9):. PubMed ID: 33054950
[TBL] [Abstract][Full Text] [Related]
8. The effect of extracorporeal photopheresis on cytokines released by leukaemic cutaneous T-cell lymphoma.
Br J Dermatol; 2023 Oct; 189(5):e97. PubMed ID: 37879744
[No Abstract] [Full Text] [Related]
9. Extracorporeal photopheresis and multimodality therapy in patients with T-cell cutaneous lymphomas: Real-life experience in Argentina.
Baquero Rey JA; Zambrano Franco EA; Andrade Miranda A; Marciano S; Mazzuoccolo LD; Enz PA
J Clin Apher; 2021 Dec; 36(6):815-822. PubMed ID: 34478581
[TBL] [Abstract][Full Text] [Related]
10. [Extracorporeal photopheresis].
Prinz B; Plewig G
Hautarzt; 1994 Nov; 45(11):746-50. PubMed ID: 7822197
[TBL] [Abstract][Full Text] [Related]
11. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution.
Gottlieb SL; Wolfe JT; Fox FE; DeNardo BJ; Macey WH; Bromley PG; Lessin SR; Rook AH
J Am Acad Dermatol; 1996 Dec; 35(6):946-57. PubMed ID: 8959954
[TBL] [Abstract][Full Text] [Related]
12. Management of cutaneous T-Cell lymphoma patients with extracorporeal photopheresis. The Hellenic experience.
Siakantaris MP; Tsirigotis P; Stavroyianni N; Argyropoulos KV; Girkas K; Pappa V; Chondropoulos S; Papadavid E; Sakellari I; Anagnostopoulos A; Antoniou C; Dervenoulas J
Transfus Apher Sci; 2012 Apr; 46(2):189-93. PubMed ID: 22178592
[TBL] [Abstract][Full Text] [Related]
13. Early intervention of extracorporeal photopheresis for advancing/progressing cutaneous T-cell lymphoma.
Aires D; Abhyankar S
Hematol Oncol; 2023 Dec; 41(5):809-816. PubMed ID: 37974524
[TBL] [Abstract][Full Text] [Related]
14. Extracorporeal photopheresis and multimodality immunomodulatory therapy in the treatment of cutaneous T-cell lymphoma.
Richardson SK; McGinnis KS; Shapiro M; Lehrer MS; Kim EJ; Vittorio CC; Junkins Hopkins JM; Rook AH
J Cutan Med Surg; 2003; 7(4 Suppl):8-12. PubMed ID: 12958701
[No Abstract] [Full Text] [Related]
15. Measuring HRQOL in patients with cutaneous T-cell lymphoma undergoing therapy with oral bexarotene and extracorporeal photopheresis.
Demierre MF; Ferzli P; Miller D
Arch Dermatol; 2007 May; 143(5):659-61. PubMed ID: 17515522
[No Abstract] [Full Text] [Related]
16. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma.
Duvic M; Chiao N; Talpur R
J Cutan Med Surg; 2003; 7(4 Suppl):3-7. PubMed ID: 12958700
[No Abstract] [Full Text] [Related]
17. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma--the Düsseldorf and Munich experience.
Prinz B; Behrens W; Hölzle E; Plewig G
Arch Dermatol Res; 1995; 287(7):621-6. PubMed ID: 8534123
[TBL] [Abstract][Full Text] [Related]
18. Invasive squamous cell carcinoma with sporotrichoid metastasis in a patient with cutaneous T cell lymphoma treated with chronic extracorporeal photopheresis.
Gmyrek R; Beer R; Elizeri Y; Oster MW; Silvers DN; Schneiderman P; Grossman ME
Cutis; 1999 Oct; 64(4):261-4. PubMed ID: 10544882
[TBL] [Abstract][Full Text] [Related]
19. [Extracorporeal photopheresis in dermatology].
Pérez-Carmona L; Harto-Castaño A; Díez-Recio E; Jaén-Olasolo P
Actas Dermosifiliogr; 2009; 100(6):459-71. PubMed ID: 19709550
[TBL] [Abstract][Full Text] [Related]
20. Extracorporeal photopheresis as a treatment for patients with cutaneous T-cell lymphoma: real-world data at a reference cancer centre in Colombia.
Toquica A; Enciso-Olivera L; Rueda-Lozada X
J Eur Acad Dermatol Venereol; 2022 Oct; 36(10):e780-e781. PubMed ID: 35596720
[No Abstract] [Full Text] [Related]
[Next] [New Search]
